Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMI5R3E)

Drug Name

(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate Drug Info

Synonyms

Glycidyl oleate; Glycidol oleate; Oleic acid glycidyl ester; 2,3-Epoxypropyl oleate; Glycidyl octadecenoate; 5431-33-4; 2,3-Epoxy-1-propanol oleate; NSC 13542; 2,3-Epoxypropyl ester of oleic acid; Oxiranylmethyl ester of 9-octadecenoic acid; Oleic acid, 2,3-epoxypropyl ester; EINECS 226-588-0; Glycidylester kyseliny olejove [Czech]; AI3-03518; CHEMBL230967; CHEBI:82469; VWYIWOYBERNXLX-KTKRTIGZSA-N; 9-OCTADECENOIC ACID (Z)-, OXIRANYLMETHYL ESTER; Oxiranyl methyl ester 9-octadecenoic acid; 9-Octadecenoic acid (9Z)-, oxiranylmet

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 5354568
ChEBI ID: CHEBI:82469
CAS Number: CAS 5431-33-4
TTD Drug ID: DMI5R3E

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Fatty acid amide hydrolase (FAAH)	DTT	FAAH	5.744	5.044	4.818	5.984

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. J Med Chem. 2007 Oct 4;50(20):5012-23.